验证数据展示
经过测试的应用
Positive WB detected in | mouse brain tissue |
推荐稀释比
应用 | 推荐稀释比 |
---|---|
Western Blot (WB) | WB : 1:500-1:2000 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
产品信息
21565-1-AP targets ATP8A1 in WB, IF, ELISA applications and shows reactivity with human, mouse, rat samples.
经测试应用 | WB, ELISA Application Description |
文献引用应用 | WB, IF |
经测试反应性 | human, mouse, rat |
文献引用反应性 | human, mouse, rat |
免疫原 | ATP8A1 fusion protein Ag16071 种属同源性预测 |
宿主/亚型 | Rabbit / IgG |
抗体类别 | Polyclonal |
产品类型 | Antibody |
全称 | ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1 |
别名 | ATP8A1, ATPase II, ATPASEII, ATPIA, ATPP2, Chromaffin granule ATPase II |
计算分子量 | 1164 aa, 131 kDa |
观测分子量 | 120 kDa |
GenBank蛋白编号 | BC109317 |
基因名称 | ATP8A1 |
Gene ID (NCBI) | 10396 |
RRID | AB_10734587 |
偶联类型 | Unconjugated |
形式 | Liquid |
纯化方式 | Antigen affinity purification |
UNIPROT ID | Q9Y2Q0 |
储存缓冲液 | PBS with 0.02% sodium azide and 50% glycerol , pH 7.3 |
储存条件 | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
实验方案
Product Specific Protocols | |
---|---|
WB protocol for ATP8A1 antibody 21565-1-AP | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
发表文章
Species | Application | Title |
---|---|---|
EMBO J Transport through recycling endosomes requires EHD1 recruitment by a phosphatidylserine translocase. | ||
Proc Natl Acad Sci U S A AP-3-dependent targeting of flippase ATP8A1 to lamellar bodies suppresses activation of YAP in alveolar epithelial type 2 cells. | ||
Sci Rep Proteomic Analysis and Functional Characterization of P4-ATPase Phospholipid Flippases from Murine Tissues. | ||
Sci Rep PPP1R12A is a recycling endosomal phosphatase that facilitates YAP activation
| ||
iScience Lipid flippase dysfunction as a therapeutic target for endosomal anomalies in Alzheimer's disease. | ||
Clin Proteomics Identification of potential molecular targets for the treatment of cluster 1 human pheochromocytoma and paraganglioma via comprehensive proteomic characterization |